Senate Health Committee Issues Testimony From Biotechnology Innovation Organization Chief Scientific Officer Esham
May 03, 2022
May 03, 2022
WASHINGTON, May 3 -- The Senate Health, Education, Labor and Pensions Committee issued the following testimony by Cartier Esham, chief scientific officer at the Biotechnology Innovation Organization, involving a hearing on April 5, 2022, entitled "FDA User Fee Agreements: Advancing Medical Product Regulation and Innovation for the Benefit of Patients".
The FDA is the Food and Drug Administration.
* * *
My name is Cartier Esham, and I am the Chief . . .
The FDA is the Food and Drug Administration.
* * *
My name is Cartier Esham, and I am the Chief . . .